BackPanbela Therapeutics Overview

Panbela Therapeutics Total Assets

Track Panbela Therapeutics's total assets ($5.2M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$5.17M
↓ 51.37% YoYΔ $-5.46M vs prior year quarter

Peer trimmed avg / median

Loading

Panbela Therapeutics Total Assets History

Loading

Panbela Therapeutics vs. peers: Total Assets Comparison

Loading

Panbela Therapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Panbela Therapeutics (PBLA) FAQ

The latest total assets for PBLA is $5.2M as of September 2024. That compares with $11M in the prior-year period — down 51.4% year over year. Investors often review this figure alongside Panbela Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, PBLA's total assets moved from $11M to $5.2M — a 51.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Panbela Therapeutics's operating scale or balance-sheet position.

A total assets figure of $5.2M for PBLA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PBLA's total assets ($5.2M), review year-over-year change from $11M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Panbela Therapeutics's total assets against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.